ask="100.00"
ask_size="600"
average_daily_volume="279494"
bid="26.00"
bid_size="100"
book_value="3.79"
change="-0.25"
change_from_200_day_moving_average="3.94"
change_from_50_day_moving_average="-1.22"
change_from_52_week_high="-4.05"
change_From_52_week_low="13.63"
change_in_percent="-0.89%"
close="27.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="28.30"
high_52_weeks="31.80"
last_trade_date="1/19/2017"
last_trade_price="27.75"
last_trade_size="2201"
last_trade_time="4:00pm"
low="27.53"
low_52_weeks="14.12"
market_capitalization="594.74M"
moving_average_200_day="23.81"
moving_average_50_day="28.97"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="28.14"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="+16.57%"
percent_change_from_50_day_moving_average="-4.20%"
percent_change_from_52_week_high="-12.74%"
percent_change_from_52_week_low="+96.53%"
previous_close="28.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.39"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="7.04"
stock_exchange="NMS"
symbol="ACRS"
volume="101382"
weeks_range_52="14.12 - 31.80"
